143 related articles for article (PubMed ID: 2505199)
1. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
[TBL] [Abstract][Full Text] [Related]
2. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin.
Ueki A; Chong PN; Albanese A; Rose S; Chivers JK; Jenner P; Marsden CD
Neuropharmacology; 1989 Oct; 28(10):1089-97. PubMed ID: 2510050
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets.
Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD
Neuropharmacology; 1989 Nov; 28(11):1211-6. PubMed ID: 2512516
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the cat.
Ambrosio S; Blesa R; Mintenig GM; Palacios-Araus L; Mahy N; Gual A
Toxicol Lett; 1988 Nov; 44(1-2):1-6. PubMed ID: 3263717
[TBL] [Abstract][Full Text] [Related]
6. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
Nomoto M; Irifune M; Fukuzaki K; Fukuda T
Neurosci Lett; 1994 Aug; 178(1):95-8. PubMed ID: 7816348
[TBL] [Abstract][Full Text] [Related]
7. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
Jenner P; Rupniak NM; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden CD
Neurosci Lett; 1984 Sep; 50(1-3):85-90. PubMed ID: 6436758
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD
Eur J Pharmacol; 1990 May; 181(1-2):97-103. PubMed ID: 2117541
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
Falardeau P; Bouchard S; Bédard PJ; Boucher R; Di Paolo T
Eur J Pharmacol; 1988 May; 150(1-2):59-66. PubMed ID: 3261249
[TBL] [Abstract][Full Text] [Related]
11. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
12. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets.
Rose S; Nomoto M; Jenner P; Marsden CD
Biochem Pharmacol; 1989 Nov; 38(21):3677-81. PubMed ID: 2597167
[TBL] [Abstract][Full Text] [Related]
13. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
[TBL] [Abstract][Full Text] [Related]
14. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
15. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
Falardeau P; Bédard PJ; Di Paolo T
Neurosci Lett; 1988 Mar; 86(2):225-9. PubMed ID: 2966905
[TBL] [Abstract][Full Text] [Related]
16. Administration of MPTP to the common marmoset does not alter cortical cholinergic function.
Garvey J; Petersen M; Waters CM; Rose SP; Hunt S; Briggs R; Jenner P; Marsden CD
Mov Disord; 1986; 1(2):129-34. PubMed ID: 3143064
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Rausch WD; Schallauer E; Chan WW; Riederer P; Weiser M
J Neural Transm Suppl; 1990; 32():269-75. PubMed ID: 1708404
[TBL] [Abstract][Full Text] [Related]
18. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Di Paolo T; Bédard P; Daigle M; Boucher R
Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
